Canada Clinical Nutrition Market, by Nutrition Type (Enteral Nutrition (Standard Nutrition, and Disease Specific Nutrition), Parenteral Nutrition (Amino Acid, Carbohydrates, Vitamins and Minerals, and Others)), by Form (Powder, Liquid, and Others), by Age Group (Infant Nutrition, Adult Nutrition, and Geriatric Nutrition), by Application (Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases, and Other Applications), and by End User (Hospitals, Ambulatory Surgical Centres, and Long Term Care Facilities), is estimated to be valued at US$ 593.0 million in 2021 and is expected to exhibit a CAGR of 4.9% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.
Personalized nutrition can be defined as developing unique nutrition guidelines for each individual based on individuals genetic, environmental, and lifestyle factors. There is an increasing use of personalized nutrition targeting the human microbiome which is expected to drive the market growth.
According to Regulatory Affairs Professionals Society (RAPS) report 2019, personalized nutritional interventions may address certain chronic conditions and provide an important contribution as preventive approaches in various health conditions such as diabetes, cancer and others.
Moreover, key players are focusing on promotional activities for their clinical nutrition brands, in order to increase brand value of their products.
For instance, Abbott Laboratories, markets its clinical nutrition products through innovative strategies such as promotional activities, to provide scientific benefits of its products as preventive medicines. For instance, in September 2019, Abbott Laboratories, teamed up with NFL star, Cleveland Browns, and Pedialyte fan, Odell Beckham Jr., to serve as a creative director for Pedialyte. Pedialyte is a brand targeted at treating rehydration, with an optimal balance of electrolytes and glucose. Adult users of Pedialyte accounted for over 50% of the product’s overall sales in 2018.
Canada Clinical Nutrition Market – Impact of Coronavirus (Covid-19) Pandemic
Factors such as investments in research and development of new nutritional product and rise in funding by several companies operating in the nutrition sector are expected to drive Canada clinical nutrition market growth during the coronavirus pandemic.
Moreover, several research institutions are conducting studies to highlight the use of nutrition in COVID-19 patients, which can further aid in the market growth.
For instance, in May 2020, researchers from University of Alberta Hospital, highlighted the deficiencies of vitamin D in COVID-19 high risk patients. In addition, the study concluded that the administration of high dose of 250,000–500,000 IU vitamin D to critically ill COVID-19 patients decreased their hospital length of stay, improved blood oxygen carrying capacity, and increased hemoglobin levels.
Furthermore, major players operating in the market are conducting programs for increasing awareness about the importance of nutritional therapies in COVID-19 patients’ recovery.
For instance, in May 2020, Fresenius Kabi AG, conducted a live webinar for highlighting the implications of nutritional therapy and COVID-19. The webinar invited healthcare professionals to learn about nutrition therapy for COVID-19 patient’s journey from ICU to discharge.
Browse 16 Market Data Tables and 31 Figures spread through 153 Pages and in-depth TOC on “Clinical Nutrition Market”- Canada Forecast to 2028, by Nutrition Type (Enteral Nutrition (Standard Nutrition, and Disease Specific Nutrition), Parenteral Nutrition (Amino Acid, Carbohydrates, Vitamins and Minerals, and Others)), by Form (Powder, Liquid, and Others), by Age Group (Infant Nutrition, Adult Nutrition, and Geriatric Nutrition), by Application (Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases, and Other Applications), and by End User (Hospitals, Ambulatory Surgical Centers and, Long Term Care Facilities)
To know the latest trends and insights prevalent in the Canada clinical nutrition market, click the link below:
Key players operating in the market are focusing on novel product approval, in order to expand their product portfolio in the market which is expected to drive the market growth during the forecast period. For instance, in February 2021, Koninklijke DSM N.V., announced the approval of new Certificate of Suitability (CEP) for vitamin D3 powder form. The CEP will help DSM’s partners to accelerate the product development process through optimal content uniformity in oral solid dose formulations.
Key Takeaways of the Canada Clinical Nutrition Market:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.